Jupiter Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Jupiter Asset Management's VIR Position: Q3 2026 in Review
Jupiter Asset Management opened a new position in Vir Biotechnology (VIR) in Q3 2026: 16,371 shares worth $183K. The stake represents ﹤0.01% of the portfolio and ranks #540 among its holdings. This is a return to the name: Jupiter Asset Management previously reported a position in VIR as recently as Q3 2023.
Jupiter Asset Management first reported a position in VIR in Q1 2023 and has held it in 4 quarters since. The position peaked at $12.3M in Q2 2023. 266 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Jupiter Asset Management held 16,371 shares of Vir Biotechnology worth $183K as of Q3 2026.
- Vir Biotechnology was a new Jupiter Asset Management position in Q3 2026.
- Vir Biotechnology made up ﹤0.01% of Jupiter Asset Management's portfolio in Q3 2026, its #540 holding.
- Jupiter Asset Management first reported a position in Vir Biotechnology in Q1 2023 and has held it in 4 quarters since.
- Jupiter Asset Management's Vir Biotechnology position peaked at $12.3M in Q2 2023.
- 266 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Jupiter Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.